StemCell Therapy

A rating of 24 puts CEL-SCI Corporation (CVM) near the bottom of the Biotechnology industry according to InvestorsObserver. CEL-SCI Corporation's score of 24 means it scores higher than 24% of stocks in the industry. CEL-SCI Corporation also received an overall rating of 36, putting it above 36% of all stocks. Biotechnology is ranked 27 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 36 means the stock is more attractive than 36 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

CEL-SCI Corporation (CVM) stock is trading at $14.94 as of 3:23 PM on Monday, Oct 12, a rise of $0.07, or 0.47% from the previous closing price of $14.87. Volume today is less active than usual. So far 366,839 shares have traded compared to average volume of 545,816 shares. The stock has traded between $14.20 and $15.23 so far today.

Click Here to get the full Stock Score Report on CEL-SCI Corporation (CVM) Stock.

Follow this link:
Is CEL-SCI Corporation (CVM) The Right Choice in Biotechnology? - InvestorsObserver

This entry was posted on October 13, 2020 at 2:59 pm and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |